SCM
INSM icon

Silverarc Capital Management’s Insmed INSM Stock Holding History

Silverarc Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-250,000
Closed -$16.8M – 76
2024
Q2 		$16.8M Buy
+250,000
New +$9.7M 3.95% 6

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Silverarc Capital Management's INSM Position: Q1 2026 in Review

Silverarc Capital Management reduced its Insmed (INSM) stake by 50% in Q1 2026, selling an estimated $5.44M and leaving 35,850 shares worth $5.86M. The position accounts for 0.6% of the portfolio, ranked #39.

Silverarc Capital Management first reported a position in INSM in Q4 2020 and has held it in 22 quarters since. The position peaked at $29.8M in Q3 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Silverarc Capital Management held 35,850 shares of Insmed worth $5.86M as of Q1 2026.
  • Silverarc Capital Management sold 35,406 Insmed shares in Q1 2026, an estimated $5.44M.
  • Insmed made up 0.6% of Silverarc Capital Management's portfolio in Q1 2026, its #39 holding.
  • Silverarc Capital Management first reported a position in Insmed in Q4 2020 and has held it in 22 quarters since.
  • Silverarc Capital Management's Insmed position peaked at $29.8M in Q3 2025.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Silverarc Capital Management's 13F filing for Q1 2026, filed 14 May 2026.